ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 134033 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 134033; 2) Community: the network communities that were significantly associated with the response to NSC 134033; 3) Molecule: the relationships between components within communities and NSC 134033; 4) MDR: the compounds that were significantly associated with the NSC 134033.

NSC Compound Enrichment Correlation
NSC 736829 6-(5-Aminopentyl)-5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]i soquinoline Hydrochloride 0.0406225271888781 0.50730156
NSC 670678 Glutamic acid, N-[4-[[[2-(ethoxycarbonyl)-3-quinoxalinyl] amino]phenyl]carbonyl]-, diethyl ester 0.0407060322613562 -0.20701708
NSC 756469 SB-732881 0.0407060322613564 -0.16326404
NSC 169774 Bromocriptine methanesulfonate 0.0462077035966081 0.14675141
NSC 22348 1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- 0.0462077035966081 0.32627664
NSC 237020 TA 1067 0.0462077035966081 0.39277465
NSC 290193 CYCLOSPORIN A 0.0462077035966081 0.18797721
NSC 317908 Null 0.0462077035966081 0.27768964
NSC 324368 3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide 0.0462077035966081 0.020774017
NSC 338643 6-Phenyl-6H-indeno[1,2-c]isoquinoline-5,11-dione 0.0462077035966081 -0.14109389
Total:115  Current:103    [First] [Prev] [Next] [Last]